The molecular biology of heart failure.

In the mammalian heart, the development of cardiac hypertrophy is a common feature that normally precedes all forms of heart failure. This adaptive process involves molecular changes in the myocardium, including the altered expression of several genes encoding proteins for contraction and relaxation. The expression of myosin heavy chain (MHC) and sarcomeric alpha-actin messenger ribonucleic acid (mRNA) changes qualitatively during cardiac hypertrophy; however, their accumulations are not coordinated. Skeletal alpha-actin transcripts accumulate throughout the ventricles and earlier than beta-MHC transcripts, which accumulate primarily around large coronary vessels. Skeletal alpha-actin transcripts also "hyperaccumulate" relative to cardiac alpha-actin mRNA, whose expression does not change. Expression of MHC isomRNA shows an inverse relation; as beta-MHC accumulates, alpha-MHC decreases in abundance. From nuclear run-on assays, we present evidence that the accumulation of these gene products is at least under partial transcriptional control with developmental growth, suggesting that those changes that occur with hypertrophy and heart failure may be primarily transcriptionally regulated. The expression of the mRNA for the calcium-adenosine triphosphate (Ca(2+)-ATPase) of the sarcoplasmic reticulum changes quantitatively with cardiac hypertrophy without the reexpression of a different isoform. The relative mRNA and protein concentrations for this protein diminish with both cardiac hypertrophy and heart failure, a change that may partially explain the delayed relaxation rates seen in hypertrophied and failing hearts.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  G. Brem,et al.  Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. , 1992, The Journal of biological chemistry.

[2]  B. Nadal-Ginard,et al.  Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. , 1989, The Journal of clinical investigation.

[3]  E. Lakatta,et al.  Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. , 1992, Circulation research.

[4]  M. Komajda,et al.  Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. , 1991, The Journal of clinical investigation.

[5]  K. Chien,et al.  Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression. , 1989, The Journal of biological chemistry.

[6]  B. Nadal-Ginard,et al.  Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Boheler,et al.  Cardiac expressions of alpha- and beta-myosin heavy chains and sarcomeric alpha-actins are regulated through transcriptional mechanisms. Results from nuclear run-on assays in isolated rat cardiac nuclei. , 1992, The Journal of biological chemistry.

[8]  A. Lompré,et al.  Changes in gene expression during cardiac growth. , 1991, International review of cytology.

[9]  M. Buckingham,et al.  α‐Skeletal Muscle Actin mRNA's Accumulate in Hypertrophied Adult Rat Hearts , 1986, Circulation research.

[10]  S. Schiaffino,et al.  Nonsynchronous Accumulation of α‐Skeletal Actin and β‐Myosin Heavy Chain mRNAs During Early Stages of Pressure‐Overload‐Induced Cardiac Hypertrophy Demonstrated by In Situ Hybridization , 1989, Circulation research.

[11]  K. Boheler,et al.  Switches in cardiac muscle gene expression as a result of pressure and volume overload. , 1992, The American journal of physiology.

[12]  R. Matsuoka,et al.  Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. , 1987, The Journal of clinical investigation.

[13]  K. Boheler,et al.  Gene expression in cardiac hypertrophy. , 1992, Trends in cardiovascular medicine.

[14]  A. Lompré,et al.  Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. , 1990, Circulation research.

[15]  L. Leinwand,et al.  Gene transfer into cardiac myocytes in vivo. , 1991, Trends in cardiovascular medicine.

[16]  K. Boheler,et al.  Description of an in vitro transcription assay in nuclei isolated from control and hemodynamically overloaded rat cardiac myocytes , 1991 .

[17]  N. Alpert,et al.  Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. , 1992, Circulation research.

[18]  H. Schunkert,et al.  Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. , 1992, The Journal of clinical investigation.

[19]  G. M. Briggs,et al.  Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. , 1991, The Journal of clinical investigation.

[20]  K. Boheler,et al.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. , 1990, The Journal of clinical investigation.

[21]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Lakatta,et al.  Progressive changes from young adult age to senescence in mRNA for rat cardiac myosin heavy chain genes. , 1991, Cardioscience.

[23]  Y. Yazaki,et al.  Molecular cloning and characterization of a Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage. , 1989, The Journal of clinical investigation.

[24]  N. Alpert,et al.  Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Lakatta,et al.  Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. , 1991, Circulation research.

[26]  W. Grossman,et al.  Diastolic dysfunction in congestive heart failure. , 1991, The New England journal of medicine.